NovoCure (NASDAQ:NVCR)

CAPS Rating: 3 out of 5

NVCR News and Commentary

Caps

How do you think NVCR will perform against the market?

Add Stock to CAPS Watchlist

All Players

19 Outperform
3 Underperform
 

All-Star Players

8 Outperform
2 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NVCR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NVCR VS S&P 500 (SPY)

NVCR Summary

Fools bullish on NVCR are also bullish on:

Fools bearish on NVCR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NVCR.

Recs

0
Member Avatar freecapital (75.04) Submitted: 7/18/2017 10:06:45 AM : Outperform Start Price: $18.35 NVCR Score: +2.64

http://boards.fool.com/1081/novocure-nvcr-32777894.aspx?sort=whole#32777894

Recs

0
Member Avatar tprooney3 (91.08) Submitted: 7/16/2017 5:09:50 PM : Outperform Start Price: $19.25 NVCR Score: -2.12

Patented, FDA approved device for cancer treatment different than surgery, radiation, or chemotherapy. Growing patient pool. Same tech could be expanded to treat infections (also patented).

Recs

0
Member Avatar Lantana3 (< 20) Submitted: 10/9/2015 2:28:28 PM : Outperform Start Price: $21.12 NVCR Score: -33.17

Novocure is not your typical IPO. It's already a 1.5 billion dollar company and has a proprietary cancer therapy with 52 patents. The FDA has approved its treatment for fighting brain tumors.

Leaderboard

Find the members with the highest scoring picks in NVCR.

Score Leader

oldlumike

oldlumike (< 20) Score: +55.50

The Score Leader is the player with the highest score across all their picks in NVCR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
oldlumike < 20 5/8/2017 Outperform 5Y $11.95 +58.52% +3.09% +55.43 0 Comment
lumike17 36.82 5/8/2017 Outperform 5Y $11.95 +58.52% +3.11% +55.41 0 Comment
headyinvestor 86.01 12/16/2015 Underperform 5Y $28.07 -32.48% +19.92% +52.40 0 Comment
stcksrus 70.69 7/27/2016 Outperform 5Y $11.69 +62.10% +13.65% +48.45 0 Comment
CMFInnovator 55.54 6/8/2017 Outperform 1Y $14.38 +31.83% +1.31% +30.51 0 Comment
lumike176 34.51 7/3/2017 Outperform 5Y $17.87 +6.05% +1.72% +4.33 0 Comment
freecapital 75.04 7/18/2017 Outperform 5Y $18.35 +3.27% +0.63% +2.64 1 Comment
jck444 89.06 7/17/2017 Outperform 5Y $18.75 +1.07% +0.44% +0.63 0 Comment
urmoney 99.72 7/18/2017 Outperform 5Y $18.86 +0.50% +0.51% -0.01 0 Comment
tprooney3 91.08 7/17/2017 Outperform 5Y $19.25 -1.56% +0.56% -2.12 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.61 10/7/2015 Outperform 3W $15.94 +18.88% +23.77% -4.89 0 Comment

Featured Broker Partners